TheEdgeResearch
Home / Stocks / EKSO

Ekso Bionics Holdings, Inc. (EKSO)

NASDAQ Technology Information Technology Services
$15.90 ▼ -9.86%
Market Cap
$38.6M
Sector
Technology
Industry
Information Technology Services
Beta
0.82
52-Wk Range
—
CEO
Scott G. Davis
Country
US
Currency
USD

Ekso Bionics Holdings, Inc. operates in the Information Technology Services industry of the Technology sector, headquartered in San Rafael, CA, US. The stock last traded at $15.90, down 9.86% on the session, giving a market capitalisation of $38.6M. On trailing twelve-month figures it carries a trailing P/E of -3.58, a net margin of -108.8%. Its beta of 0.82 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-3.58
Price / Sales
0.76
Price / Book
15.35
EV / EBITDA
-3.58
Gross margin
2.3%
Operating margin
-74.4%
Net margin
-108.8%
Return on equity
—
Debt / equity
0.74
Current ratio
0.30
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
53
IPO date
2014-01-15
Headquarters
San Rafael, CA, US
About Ekso Bionics Holdings, Inc.

Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Comparable companies

Ekso Bionics Holdings, Inc. is most often compared with the following Technology names:

AEMDALURANLAYTUCODXERNAGOVXNVNOOSRHPRPH
More research on EKSO
EKSO technical analysis EKSO TheEdge Score Compare against peers
Open full interactive analysis & DCF →